Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 56.22% vs 145.15% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 42.21% vs 152.04% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 24.37% vs 5.92% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 58.47% vs 130.10% in Mar 2024
Compare Profit and Loss Results of Asston Pharmaceu
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
25.00
285.00
-260.00
-91.23%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
25.00
285.00
-260.00
-91.23%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-2.00
2.00
100.00%
Raw Materials Consumed
14.00
269.00
-255.00
-94.80%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
1.00
2.00
-1.00
-50.00%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
275.00
-256.00
-93.09%
Operating Profit (PBDIT) excl Other Income
5.00
10.00
-5.00
-50.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
6.00
11.00
-5.00
-45.45%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
5.00
10.00
-5.00
-50.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
5.00
9.00
-4.00
-44.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
9.00
-4.00
-44.44%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
3.00
7.00
-4.00
-57.14%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3.00
61.00
-58.00
-95.08%
Profit Available for appropriations
7.00
69.00
-62.00
-89.86%
Appropriations
7.00
69.00
-62.00
-89.86%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
6.14
23.02
-16.88
-73.33%
Profit And Loss - Net Sales
Net Sales 25.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 56.22% vs 145.15% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.21% vs 152.04% in Mar 2024
Profit And Loss - Interest
Interest 0.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.37% vs 5.92% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 3.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 58.47% vs 130.10% in Mar 2024






